Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HV4B
|
|||
| Drug Name |
ADCT-402
|
|||
| Indication | Acute lymphoblastic leukaemia [ICD-11: 2A85; ICD-10: C85.1, C88.7] | Phase 1 | [1] | |
| B-cell non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 1 | [1], [2] | ||
| Burkitt cell leukaemia [ICD-11: 2A85.6; ICD-10: C83.7, C91.8] | Phase 1 | [2] | ||
| Company |
ADC Therapeutics Murray Hill, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.